EU Deadlock Over Biotech Products Unbroken
237988
European Union governments failed to break a deadlock Monday on whether to allow imports of a corn modified by U.S. biotech giant Monsanto Co. to resist rootworms, despite a ruling last month confirming its safety.
761882
The European Union's patchwork of rules on copyright levies, which can mean hundreds of dollars in price differences between conries on goods such as mobile phones, MP3 players and even paper, will not be overhauled in the near future despite pleas from industry groups, artists, and France.
633029
Several influential EU states have dug  in their heels on whether their farmers may grow one of  Europe&#39;s oldest genetically modified (GMO) crops, raising the  stakes in the EU&#39;s long-running stalemate over biotech policy.
493817
MEPs still mulling it over The European Parliament has once again postponed the vote on the latest version of the Intellectual Property Rights (IPR) directive. This time, the delay is to "find a final compromise" on the definition of what will consitute "commercial scale" infringement under the new proposals.â¦
115602
The European Union has said it will not appeal a World Trade Organisation ruling that partially condemned the bloc for its moratorium on imports of genetically modified organisms.
673676
The European Union has taken a step closer to tough new chemicals rules after EU lawmakers and governments hammered out the details of one of Europe's most ambitious and disputed legislative packages in years.
240121
Drugmakers get part of the job done outside of the U.S.
371568
The European Union rejects Neurochem's lead drug.
187176
Increasing the tension over government subsidies to Airbus and Boeing, yesterday&#39;s latest round of talks between the United States and the European Union ended in deadlock.
147715
BRUSSELS, Jul 20 (IPS) - The European Union&#39s only directly elected  institution is at loggerheads with the bloc&#39s 27 governments  over a measure officially designed to ensure that poor countries  have access to affordable medicines.
28653
Biotech and high technology, two key Massachusetts industries, are often seen as allies -- innovation-driven businesses that depend on a highly educated workforce. But this week they're on opposite sides of a fight playing out in Washington: How to overhaul the nation's patent system.
183865
The harvesting of stem cells from human embryos will continue to be funded by the EU, the incoming European Union research chief said on Friday, vowing to keep an open mind while taking ethical views into account.
336226
Biogen Idec's chief executive, James Mullen, says the Cambridge biotechnology company is unlikely to receive approval from European regulators to use its drug Tysabri to treat patients with Crohn's disease, a debilitating intestinal ailment.
121380
THE future of AstraZenecaâs blood-thinning medicine, Exanta, was thrown into fresh doubt last night after Franceâs leading drugs regulator confirmed that it was reviewing the medicineâs approval status.
481346
EU ministers ended 18 months of squabbling on Tuesday over new rules for organic farming and came up with a labeling system that will tell consumers exactly what they are buying on the supermarket shelves.
87058
In Europe, industry leaders, government officials and others debate whether patents would hinder or cultivate innovation.
102128
The European Union has failed in its attempt to get special protection for food and drinks brands associated with their place of production, reports say.